| A Study In Healthy Volunteers To Assess The Safety, Tolerability, And Relative Oral Bioavailability Of Three Formulations Of PH-797804 (NCT01226693) | Pfizer | 2010-11-01 |
| To Evaluate The Relationship Between Plasma Drug Levels And Receptor Binding In Brain Using PET (Positron Emission Tomography) In Healthy Volunteers (NCT01253655) | Pfizer | 2010-11-01 |
| A Study In Healthy Subjects Of Single Doses of PF-05230901 Injected Under The Skin (NCT01262690) | Pfizer | 2010-11-01 |
| Estimate The Effect Of Lersivirine On The Pharmacokinetics Of Abacavir/Lamivudine In Healthy Subjects (NCT01220232) | Pfizer | 2010-11-01 |
| A Study Of PF-05175157 In Healthy Volunteers (NCT01274663) | Pfizer | 2010-11-01 |
| A Pharmacokinetic Drug-Drug Interaction (DDI) Study Between Sitaxsentan And Sildenafil, And Between Sitaxsentan And Tadalafil After Multiple Doses (NCT01244620) | Pfizer | 2010-11-01 |
| A Study Evaluating the Absorption Of Varenicline Through The Skin Following Once Daily Application Of A Patch For 14 Days (NCT01234142) | Pfizer | 2010-11-01 |
| A Study to Assess the Antibody Response of Healthy Chinese Children Who Have Been Vaccinated Previously With 4-doses of Prevenar (a Pneumococcal Vaccine) as Babies and Toddlers (NCT01298544) | Pfizer | 2010-11-01 |
| Pharmacokinetics Of Orally Administered Fx-1006A In Subjects With Hepatic Dysfunction (NCT01358565) | Pfizer | 2010-11-01 |
| Safety And Efficacy Of Tanezumab In Patients With Chronic Pancreatitis (NCT01146561) | Pfizer | 2010-10-13 |
| Safety, Tolerability and Relative Bioavailability of Pegvisomant in Healthy Subjects (NCT01181973) | Pfizer | 2010-10-01 |
| Study Evaluating a 13-valent Pneumococcal Conjugate Vaccine in Preterm Compared to Term Infants. (NCT01193335) | Pfizer | 2010-10-01 |
| A Comparison Of A Single PF-04634817 Tablet Dose Compared With A Solution In Healthy Volunteers (NCT01247883) | Pfizer | 2010-10-01 |
| The Study of Unasyn-S 12g/Day for Community Acquired Pneumonia (CAP) (NCT01189487) | Pfizer | 2010-10-01 |
| Effects of Tofacitinib (CP-690,550) on Magnetic Resonance Imaging (MRI)- Assessed Joint Structure In Early Rheumatoid Arthritis (RA) (NCT01164579) | Pfizer | 2010-10-01 |
| CP-690,550 Pharmacokinetics In Healthy Chinese Subjects (NCT01101919) | Pfizer | 2010-10-01 |
| Safety And Tolerability Of Multiple Dose Lersivirine For 21 Days In Healthy Subjects (NCT01230385) | Pfizer | 2010-10-01 |
| Multiple Oral Doses Of PH-797804 In Healthy Japanese Adult Subjects (NCT01217918) | Pfizer | 2010-10-01 |
| Correlation Between Beliefs About Medicine and Objective Measures of Efficacy and Safety in Rheumatoid Arthritis (RA) (NCT01432366) | Pfizer | 2010-10-01 |
| Evaluate Azithromycin Plus Chloroquine And Sulfadoxine Plus Pyrimethamine Combinations For Intermittent Preventive Treatment Of Falciparum Malaria Infection In Pregnant Women In Africa (NCT01103063) | Pfizer | 2010-10-01 |
| An Inpatient Study Of The Efficacy, Safety, And Tolerability Of PF-02545920 In The Treatment Of Acute Exacerbation Of Schizophrenia (NCT01175135) | Pfizer | 2010-10-01 |
| A Study To Estimate The Time Course Of PF-00241939 Concentration In The Blood After Dosing With Oral Inhalation From Dry Powder Inhalers (NCT01181700) | Pfizer | 2010-10-01 |
| A Study Of The Safety, Tolerability And Effective Of Voriconazole For The Treatment Of Serious Candida Infection And Candida Infection Of The Throat In Pediatric Patients (NCT01092832) | Pfizer | 2010-10-01 |
| Study Evaluating A Novel Ibuprofen Formulation In The Treatment Of Dental Pain (NCT01216163) | Pfizer | 2010-10-01 |
| Trial Evaluating a 13-valent Pneumococcal Conjugate Vaccine Given With Diphtheria, Tetanus, and Acellular Pertussis Vaccine (DTaP) in Healthy Japanese Infants (NCT01200368) | Pfizer | 2010-09-24 |
| A Safety and Efficacy Study of Oral MDV3100 in Chemotherapy-Naive Patients With Progressive Metastatic Prostate Cancer (NCT01212991) | Pfizer | 2010-09-16 |
| Study Evaluating Safety Of BMP-655/ACS As An Adjuvant Therapy For Rotator Cuff Repair (NCT00936559) | Pfizer | 2010-09-01 |
| Study Evaluating The Safety Of AAB-003 (PF-05236812) In Subjects With Alzheimer's Disease (NCT01193608) | Pfizer | 2010-09-01 |
| A Long Term Study To Evaluate The Safety And Tolerability Of CP-690,550 For Patients With Moderate To Severe Chronic Plaque Psoriasis (NCT01163253) | Pfizer | 2010-09-01 |
| Evaluating The Safety Of Exemestane Following 2-3 Years Of Adjuvant Tamoxifen Therapy In Postmenopausal Early Breast Cancer Patients (NCT01155063) | Pfizer | 2010-09-01 |
| Effect Of Ketoconazole On The Pharmacokinetics Of Tasocitinib (CP-690,550) In Healthy Volunteers (NCT01202240) | Pfizer | 2010-09-01 |
| A Bioequivalence Study Of Ethinylestradiol + Gestodene In Female And Healthy Volunteers. (NCT01260805) | Pfizer | 2010-09-01 |
| A First In Human Study In Healthy People To Evaluate Safety, Toleration And Time Course Of Plasma Concentration Of Single Inhaled Doses Of PF-05212372. (NCT01415102) | Pfizer | 2010-09-01 |
| A Study To Assess The Safety And Effectiveness Of Prevenar In Chinese Children Who Have Not Previously Received A Vaccine Against Pneumococcal Bacteria (NCT01193582) | Pfizer | 2010-09-01 |
| Prevenar Special Use-result Surveillance in Japan (Regulatory PostMarketing Commitment Plan) (NCT01521897) | Pfizer | 2010-09-01 |
| Effect of Prevnar 13 on Ear Infections in Children (NCT01199016) | Pfizer | 2010-09-01 |
| A Study To Evaluate The Effects And Safety Of Treatment, Treatment Withdrawal, Followed By Re-Treatment With CP-690,550 In Subjects With Moderate To Severe Chronic Plaque Psoriasis (NCT01186744) | Pfizer | 2010-09-01 |
| Study In Healthy Subjects To Evaluate The Changes In The Protein sAPP-Alpha In Cerebrospinal Fluid Following A Single Oral Dose Of PF-04995274 (NCT01193062) | Pfizer | 2010-09-01 |
| Phase 1 Study To Test the Bioequivalence Between Two 25 mg Tablets vs. One 50 mg Tablet Under Fast/Fed Condition and Evaluate Food Effect of Desvenlafaxine Succinate Sustained Release (DVS SR) (NCT01190514) | Pfizer | 2010-09-01 |
| NeisVac-C Single Prime Study in Infants (NCT01218451) | Pfizer | 2010-09-01 |
| A Study To Evaluate The Effect Of Food On How Tasocitinib (CP-690,550) Is Absorbed And Moves Through The Body Following Oral Administration Of Tasocitinib (CP-690,550) Tablets To Healthy Subjects (NCT01184001) | Pfizer | 2010-09-01 |
| Estimate The Effect Of Repeat-Dose Rifampin On The Pharmacokinetics Of CP-690,550 In Healthy Volunteers (NCT01204112) | Pfizer | 2010-09-01 |
| Temsirolimus (Torisel) Drug Use Investigation (Regulatory Post Marketing Commitment Plan) (NCT01210482) | Pfizer | 2010-08-24 |
| Safety And Tolerability Study Of RN6G In Subjects With Advanced Dry, Age-Related Macular Degeneration Including Geographic Atrophy (NCT01003691) | Pfizer | 2010-08-05 |
| PF-00489791 For The Treatment Of Raynaud's (NCT01090492) | Pfizer | 2010-08-04 |
| Acute Response Capsaicin Flare Study (NCT01147432) | Pfizer | 2010-08-01 |
| Single Dose Study Of PF-04308515 And Prednisone On Carbohydrate (NCT01199029) | Pfizer | 2010-08-01 |
| A Study To Compare The Amount Of Tasocitinib (CP-690,550) That Is Absorbed Into The Blood Of Healthy Subjects Following Oral Administration Of Three Different Tablet Versions Of Tasocitinib (CP-690,550) (NCT01184092) | Pfizer | 2010-08-01 |
| A Phase 1 Absolute Bioavailability Study For Oral Crizotinib In Healthy Volunteers (NCT01168934) | Pfizer | 2010-08-01 |
| A Safety and Efficacy Study of Two Dose Levels of Taliglucerase Alfa in Pediatric Subjects With Gaucher Disease (NCT01132690) | Pfizer | 2010-08-01 |
| Cross Over Convenience And Preference Study Of New Mark VII Compared To Genotropin Pen In Pediatric And Adult Subjects (NCT01112865) | Pfizer | 2010-08-01 |
| To Evaluate The Relationship Between Plasma Drug Levels And Receptor Binding In Brain Using PET (Positron Emission Tomography) In Healthy Volunteers (NCT01173757) | Pfizer | 2010-08-01 |
| A Study Of Combined C- MET Inhibitor And PAN-HER Inhibitor (PF-02341066 And PF-00299804) In Patients With Non- Small Cell Lung Cancer (NCT01121575) | Pfizer | 2010-08-01 |
| Triazolam Trial In Healthy Subjects To Compare Bioavailability Between Formulations Of Triazolam To Determine Their Bioequivalence In Terms Of Rate And Magnitude Of Absorption (NCT01017926) | Pfizer | 2010-08-01 |
| A Multiple Dose Study Of PF-05161704 In Healthy Volunteers (NCT01202266) | Pfizer | 2010-08-01 |
| Pharmacokinetics And Safety Study Of Two CP-690,550 Controlled Release Formulation Following Single Dose In Healthy Volunteers (NCT01185184) | Pfizer | 2010-08-01 |
| A Study to Evaluate the Safety and Efficacy of Three Doses of a Controlled Release Formulation of Varenicline for Smoking Cessation (NCT00741884) | Pfizer | 2010-08-01 |
| A Clinical Study Evaluating The Safety And Tolerability Of PF-04427429 In Healthy Adult Volunteers. The Pharmacokinetics And Pharmacodynamics Of PF-04427429 Will Also Be Investigated (NCT01165723) | Pfizer | 2010-08-01 |
| Conversion to Embeda With Rescue Trial (NCT01179191) | Pfizer | 2010-08-01 |
| A 12 Week Safety And Efficacy Study Of Sitaxentan Sodium In Japanese Pulmonary Arterial Hypertension Patients (NCT01204853) | Pfizer | 2010-08-01 |
| A Study To Observe Safety And Blood Concentrations Of PF-04995274 During And Following the Administration of Multiple Doses Of PF-04995274 In Healthy Adult And Healthy Elderly Volunteers. (NCT01169714) | Pfizer | 2010-08-01 |
| Bioequivalence And Food Effect Study Comparing The Commercial Formulation Of Crizotinib To Its Clinical Study Formulations And Commercial Formulation With Or Without Food In Healthy Volunteers (NCT01154218) | Pfizer | 2010-08-01 |
| Open-Label Drug Interaction Study Evaluating Desvenlafaxine Succinate Sustained Release (DVS SR) 100mg On The Pharmacokinetics Of Tamoxifen When Coadministered To Healthy Post-Menopausal Female Subjects (NCT01189500) | Pfizer | 2010-08-01 |
| Abuse Potential Assessment of Intranasally Administered EMBEDA Compared To Morphine Sulfate Controlled Release And Placebo (NCT01595867) | Pfizer | 2010-08-01 |
| Multiple Dose Healthy Volunteer Study of PF-03715455. (NCT01186757) | Pfizer | 2010-08-01 |
| Open Label Drug Interaction Study Evaluating Desvenlafaxine Succinate Sustained Release (DVS SR) 100mg On The Pharmacokinetics Of Aripiprazole When Coadministered To Healthy Subjects (NCT01188668) | Pfizer | 2010-08-01 |
| Single Dose Study Of PF-04171327 And Prednisone On Carbohydrate Metabolism (NCT01199900) | Pfizer | 2010-08-01 |
| Multiple-Dose Safety Study Of RN316 For TheTreatment Of Hypercholesterolemia (NCT01163838) | Pfizer | 2010-08-01 |
| Prevalence of Psoriatic Arthritis in Adults With Psoriasis: An Estimate From Dermatology Practice (NCT01147874) | Pfizer | 2010-08-01 |
| Post-Authorisation Safety Cohort Observation of RetacritTM (Epoetin Zeta) Administered Subcutaneously for the Treatment of Renal Anaemia (NCT01543477) | Pfizer | 2010-07-07 |
| Pharmacokinetic And Pharmacodynamic Study Of A Single-Dose Of PF-04950615 (RN316) In Combination With Atorvastatin (NCT01163851) | Pfizer | 2010-07-01 |
| Cost Effectiveness Of Linezolid In Central America (NCT01040585) | Pfizer | 2010-07-01 |
| A Study Of The Safety And Efficacy Of PF-04191834 In Patients With Osteoarthritis Of The Knee (NCT01147458) | Pfizer | 2010-07-01 |
| Pharmacokinetics, Safety and Tolerability Study of PF-03463275 in Healthy Male Japanese and Western Subjects (NCT01159626) | Pfizer | 2010-07-01 |
| To Calculate the Pharmacokinetics (Concentration of Compound in and Rate of Excretion From the Blood) Following a Very Low Dose of Compound Which Will Not Have Any Pharmacological Activity (NCT01165736) | Pfizer | 2010-07-01 |
| Study Estimating the Impact of Prevnar 13™ (13vPnC) on Invasive Pneumococcal Disease (NCT01128439) | Pfizer | 2010-07-01 |
| Estimation Of Effect Of Rifampin On Pharmacokinetics Of Crizotinib In Healthy Volunteers (NCT01147055) | Pfizer | 2010-07-01 |
| Study Of The Effect Of CP-751,871 In Combination With Gemcitabine And Cisplatin In Patients With Advanced Non-Small Cell Lung Cancer (NCT00907504) | Pfizer | 2010-07-01 |
| Study Providing Monotherapy (Sitaxsentan) And Combination Therapy (Sitaxsentan+Sildenafil) To Subjects With Pulmonary Arterial Hypertension (PAH) To Assess Long-Term Safety (NCT00796510) | Pfizer | 2010-07-01 |
| A Phase II, Dose Ranging Study Of CP-690,550 Eye Drops In Patients With Dry Eye Disease (NCT01135511) | Pfizer | 2010-07-01 |
| Multiple Ascending Dose Study To Assess Safety, Tolerability And Pharmacokinetics Of PF-05212377 (SAM-760) (NCT01159496) | Pfizer | 2010-07-01 |
| Efficacy And Safety Of Sunitinib In Patients With Advanced Well-Differentiated Pancreatic Neuroendocrine Tumors (NCT01121562) | Pfizer | 2010-07-01 |
| A Study To Estimate The Amount Of CP-690,550 (Study Drug) That Is Absorbed Into The Blood Of Healthy Subjects Following Oral Administration Of CP-690,550 In Tablet Form (NCT01143805) | Pfizer | 2010-07-01 |
| Varenicline (Champix®) Special Investigation (Regulatory Post Marketing Commitment Plan) (NCT01061710) | Pfizer | 2010-07-01 |
| A Single Dose Study Of PF-05161704 In Healthy Volunteers (NCT01183715) | Pfizer | 2010-07-01 |
| A Clinical Study To Characterize The Pharmacokinetics And The Effects Of Food On Oxycodone In Healthy Volunteers (NCT01530542) | Pfizer | 2010-07-01 |
| Estimation Of Effect Of Ketoconazole On Pharmacokinetics Of Crizotinib In Healthy Volunteers (NCT01149785) | Pfizer | 2010-07-01 |
| Acute Effects Of Donepezil On Brain Perfusion And Memory In Subjects With Cognitive Impairment And Mild Alzheimer's Disease (NCT01082965) | Pfizer | 2010-07-01 |
| Health Outcomes in Rheumatoid Arthritis in Greece (NCT01001182) | Pfizer | 2010-07-01 |
| A Single Dose Study Of PF-04620110 In Healthy Subjects (NCT01166217) | Pfizer | 2010-07-01 |
| Study To Evaluate The Effect Of A Multiple Oral Dose Of PF-00232798 On QT Intervals In Healthy Subjects (NCT01140425) | Pfizer | 2010-07-01 |
| Brain Imaging To Examine The Effect Of Naproxen In Hand Osteoarthritis Patients (NCT00830050) | Pfizer | 2010-07-01 |
| A Study to Assess the Cognitive Effects of Fesoterodine in Elderly Subjects (NCT01161472) | Pfizer | 2010-07-01 |
| Safety Extension Study Of Tanezumab When Administered By Subcutaneous Injection To Patients With Osteoarthritis (NCT01127893) | Pfizer | 2010-06-15 |
| A Study Of The Efficacy And Safety Of CP-601,927 Augmentation Of Antidepressant Therapy In Major Depression (NCT01098240) | Pfizer | 2010-06-14 |
| Amlodipine And Olmesartan Medoxomil In Hypertensive Filipino Patients (NCT01200407) | Pfizer | 2010-06-09 |
| National Trends in Otitis Media in Children Under 5 Years of Age (NCT01339546) | Pfizer | 2010-06-09 |
| A Study To Investigate The Safety And Toleration Of Multiple Oral Doses Of PF-03654764 In Combination With Fexofenadine In Healthy Subjects (NCT01298505) | Pfizer | 2010-06-04 |
| Study To Determine The Pharmacokinetics Of Sulfasalazine In Children With Juvenile Idiopathic Arthritis (NCT00637780) | Pfizer | 2010-06-01 |
| Bioequivalence Study Of Diltiazem In 60 Mg Tablets As Tilazem 60® Made by Pfizer, S.A. De C.V., Versus Angiotrofin® 60 Mg Made by Amstrong Laboratorios De Mexico, S.A. De C.V. (NCT01151345) | Pfizer | 2010-06-01 |